PHBI.US Pharmagreen Biotech Inc

Healthcare Pharmaceuticals USA Stocks
0.3340 USD
Close of Oct 10, 2026
0.1359 7.00
Market cap
USD 231M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2026.

Is PHBI.US undervalued?

Graham number

The Graham number of Pharmagreen Biotech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmagreen Biotech Inc fundamental analysis

No fundamental analysis for Pharmagreen Biotech Inc yet.

Pharmagreen Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmagreen Biotech Inc

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and …

Full company profile